Zydus's API unit at Dabhasa, Gujarat concludes USFDA inspection
With 6 observations
Zydus Lifesciences announced that the USFDA conducted a surveillance inspection at the group's API Unit, located at Dabhasa in Gujarat. The inspection was conducted from April 21st to 25th, 2025.The inspection concluded with 6 observations and none of them were related to Data Integrity. The company is confident to address the observations expeditiously.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Apr 26 2025 | 11:57 AM IST